 |
| 미국 캘리포니아 새크라멘토 SK팜테코 본사 (사진=SK) |
[Alpha Biz=(Chicago) Reporter Paul Lee] Five domestic and foreign private equity funds (PEFs) expressed their intention to participate in the pre-IPO (pre-IPO) of SK Pharmteco, a biopharmaceutical CDMO (consignment development and manufacturing) company of the SK Group.
According to the IB (investment banking) industry on the 9th, Credit Suisse (CS) and Morgan Stanley, the organizers of the pre-IPO, received letters of intent from domestic and foreign PEFs such as IMM PE (Private Equity), STIC Investments, and Stone Bridge Capital.
This investment attraction will be conducted through a limited bidding method. The exact scale is not known, but the IB industry expects that SK Pharmteco will raise 400 to 600 billion won through this pre-IPO.
Previously, SK Pharmteco announced at the 40th JP Morgan Healthcare Conference held in January last year that it would pursue a pre-IPO and materialize its IPO plan.
Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)
